Observations on the systemic effect of topical clobetasol propionate (Dermovate).
Authors:
- J A CarruthersJCJ A Carruthers
- P J AugustPAP J August
- R C StaughtonRSR C Staughton
Abstract
Topical application of clobetasol propionate in a strength of 0-05% in cream or ointment (Dermovate) suppressed the hypothalamic-pituitary-adrenal axis in both normal people and patients with diseased skin. In normal people the 9 am serum cortisol level was suppressed when between 45 and 90 g was applied weekly. Insulin stress test results in patients with diseased skin showed an abnormally small response after long-term application of similar amounts. We conclude that long-term administration should be restricted to less than 50 g a week.Keywords
This publication has 8 references indexed in Scilit:
- ADRENAL SUPPRESSION BY CLOBETASOL PROPIONATEThe Lancet, 1975
- Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.BMJ, 1975
- Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment.BMJ, 1975
- Pustular Psoriasis with Adrenal Suppression following Topical CorticosteroidsProceedings of the Royal Society of Medicine, 1974
- ADRENAL UNRESPONSIVENESS ASSOCIATED WITH CLOBETASOL PROPIONATEThe Lancet, 1974
- GENERALIZED PUSTULAR PSORIASIS.British Journal of Dermatology, 1968
- Some Studies of the Protein-Binding of Steroids and Their Application to the Routine Micro and Ultramicro Measurement of Various Steroids in Body Fluids by Competitive Protein-Binding Radioassay1The Journal of Clinical Endocrinology & Metabolism, 1967
- THE ADRENOCORTICAL RESPONSE TO INSULIN-INDUCED HYPOGLYCAEMIAJournal of Endocrinology, 1963